MBII
Marrone Bio Innovations, Inc.
MBII
MBII
Delisted
MBII was delisted on the 12th of July, 2022.
49 hedge funds and large institutions have $49M invested in Marrone Bio Innovations, Inc. in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
17
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$786K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$513K |
| 3 |
Morgan Stanley
New York
|
+$55.2K |
| 4 |
JPMorgan Chase & Co
New York
|
+$51K |
| 5 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$50.5K |
Top Sellers
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$317K |
| 2 |
Millennium Management
New York
|
-$133K |
| 3 |
Goldman Sachs
New York
|
-$108K |
| 4 |
BlackRock
New York
|
-$68.6K |
| 5 |
Jane Street
New York
|
-$35K |
